Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|January 22, 2023
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation InotuzumabVaibhav Agrawal, Hoda Pourhassan, Ni-Chun Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute LeukemiaAnthony Stein, Joycelynne Palmer, Ni-Chun Tsai, et al.
Bone Marrow Transplantation|February 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effectPaul B Koller, Tamer Othman, Dongyun Yang, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Frontiers in Immunology|March 7, 2025
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxisDiana T Samuels, Janny M Yao, Yazeed Samara, et al.
Haematologica|October 4, 2017
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of <i>TP53</i> mutational statusIbrahim Aldoss, Anh Pham, Sierra Min Li, et al.
Blood Advances|July 11, 2022
Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALLIbrahim Aldoss, Dongyun Yang, Vanina Tomasian, et al.
Blood Advances|January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALLIbrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Transplantation and Cellular Therapy|March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell TransplantationJorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Pageof 7